Oral immunotherapy with immunodominant T-cell epitope peptides alleviates allergic reactions in a Balb/c mouse model of egg allergy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 1, 2012, Pages 74-82

  Rupa, P ^a   Mine, Y ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

food allergy; immune modulation; oral immunotherapy; Ovomucoid; T regulatory cells; T cell epitope

Indexed keywords

ASPARTYLASPARAGINYLLYSYLTHREONYLTYROSYLGLYCYLASPARAGINYLLYSYLSERYLASPARAGINYLPHENYLALANYLSERYLASPARAGINYLALANYLVALINE; EPITOPE; GAMMA INTERFERON; HISTAMINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 4; OVOMUCOID; POLYPEPTIDE; SYNTHETIC PEPTIDE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BAGG ALBINO MOUSE; CD4+ CD25+ T LYMPHOCYTE; CD4+ FOXP3 T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CIRCULAR DICHROISM; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EGG ALLERGY; FEMALE; FLOW CYTOMETRY; HISTAMINE BLOOD LEVEL; IMMUNOREGULATION; MOUSE; NONHUMAN; ORAL IMMUNOTHERAPY; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; REGULATORY T LYMPHOCYTE; SENSITIZATION;

ADMINISTRATION, ORAL; ANIMALS; CELL SEPARATION; DESENSITIZATION, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; EGG HYPERSENSITIVITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; IMMUNODOMINANT EPITOPES; MICE; MICE, INBRED BALB C; OVOMUCIN; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; T-LYMPHOCYTES, REGULATORY;

EID: 83555161730     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2011.02724.x     Document Type: Article

References (35)

1. Rolland JE, Gardner LM, O'Hehir RE,. Allergen-related approaches to immunotherapy. Pharmacol Ther 2009; 121: 273-284.
2. Verhoef A, Alexander C, Kay AB, Larché M,. T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity. PLoS Med 2005; 2: 253-261.
3. Campbell JD, Buckland KF, McMillan SJ,. Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J Exp Med 2009; 206: 1535-1547.
4. Ozdemir C, Akdis M, Akdis CA,. T regulatory cells and their counterparts: masters of immune regulation. Clin Exp Allergy 2009; 39: 626-639.
5. Ozdemir C, Akdis M, Akdis CA,. T cell response to allergens. Chem Immunol Allergy 2010; 95: 22-44.
6. Yang M, Mine Y,. Multiple T cell epitope peptides suppress allergic responses in an egg allergy mouse model by the elicitation of forkhead box transcription factor 3- and transforming growth factor-beta-associated mechanisms. Clin Exp Allergy 2010; 40: 668-678.
7. Mine Y, Yang M,. Epitope characterization of ovalbumin in BALB/c mice using different entry routes. Biochim Biophys Acta 2007; 1774: 200-212. (Pubitemid 46205493)
8. Yang M, Mine Y,. Novel T-cell epitopes of ovalbumin in BALB/c mouse: potential for peptide-immunotherapy. Biochem Biophys Res Commun 2009; 378: 203-208.
9. Clark AT, Islam S, King Y, Deighton J, Anagnostou K, Ewan PW,. Successful oral tolerance induction in severe peanut allergy. Allergy 2009; 64: 1218-1220.
10. Varshney P, Jones SM, Scurlock AM, et al., A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 2011; 27: 654-660.
11. Itoh N, Itagaki Y, Kurihara K,. Rush specific oral tolerance induction in school-age children with severe egg allergy: one year follow up. Allergol Int 2010; 59: 43-51.
12. Meglio P, Giampietro PG, Gianni S, Galli E,. Oral desensitization in children with immunoglobulin E-mediated cow's milk allergy- follow-up at 4 yr and 8 months. Pediatr Allergy Immunol 2008; 19: 412-419. (Pubitemid 351989319)
13. Takagi H, Hiroi T, Yang L,. A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses. Proc Natl Acad Sci USA 2005; 102: 17525-17530. (Pubitemid 41740899)
14. Takaiwa F,. A rice-based edible vaccine expressing multiple T-cell epitopes to induce oral tolerance and inhibit allergy. Immunol Allergy Clin North Am 2007; 27: 129-139. (Pubitemid 46185905)
15. Murasugi T, Nakagami Y, Yoshitomi T, Hirahara K, Yamshita M, Taniguchi Y, et al., Oral administration of a T cell epitope inhibits symptoms and reactions of allergic rhinitis in Japanese cedar pollen allergen-sensitized mice. Eur J Pharmacol 2005; 510: 143-148. (Pubitemid 40312400)
16. Hirahara K, Hirahara K, Saito S, Serizawa N, Sasaki R, Sakaguchi M, et al., Oral administration of a dominant T-cell determinant peptide inhibits allergen-specific Th1 and Th2 cell responses in Cry j 2-primed mice. J Allergy Clin Immunol 1998; 102: 961-967. (Pubitemid 29018313)
17. Prickett SR, Voskamp AL, Dacumos-Hill A, Symons K, Rolland JM, O'Hehir RE,. Ara h 2 peptides containing dominant CD4 (+) T-cell epitopes: candidates for a peanut allergy therapeutic. J Allergy Clin Immunol 2011; 127: 608-615.
18. Mizumachi K, Kurisaki J,. Localization of T-cell epitope regions of chicken ovomucoid recognized by mice. Biosci Biotechnol Biochem 2003; 67: 712-719. (Pubitemid 39251899)
19. Zhang JW, Mine Y,. Characterization of IgE and IgG epitopes on ovomucoid using egg-white-allergic patients' sera. Biochem Biophys Res Commun 1998; 253: 124-127. (Pubitemid 29015611)
20. Rupa P, Nakamura S, Mine Y,. Genetically glycosylated ovomucoid third domain can modulate Immunoglobulin E antibody production and cytokine response in Balb/c mice. Clin Exp Allergy 2007; 37: 918-928. (Pubitemid 47074552)
21. Rupa P, Mine Y,. Structural and immunological characterization of recombinant ovomucoid expressed in Escherichia coli. Biotechnol Lett 2003; 25: 427-433. (Pubitemid 36325830)
22. Akdis M, Akdis CA,. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2007; 119: 780-791.
23. Ando H, Moverare R, Kondo Y, Tanaka A, Borres MP, Urisu A,. Utility of ovomucoid-specific IgE concentrations in predicting symptomatic egg allergy. J Allergy Clin Immunol 2008; 122: 583-588.
24. Strait RT, Morris SC, Finkelman FD,. IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking. J Clin Invest 2006; 116: 833-841. (Pubitemid 43326893)
25. Rupa P, Schmied J, Wilkie BN,. Prophylaxis of experimentally induced ovomucoid allergy in neonatal pigs using Lactococcus lactis. Vet Immunol Immunopathol 2011; 140: 23-29.
26. Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, Culpepper JA, et al., Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD41 T cells. J Immunol 1995; 154: 5071-5079.
27. Tarzi M, Klunker S, Texier C, Verhoef A, Stapel SO, Akdis CA, et al., Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy. Clin Exp Allergy 2006; 36: 465-474.
28. Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H, Shevach EM., CD4 (+) CD25 (+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med 2002; 196: 237-246.
29. Curotto de Lafaille MA, Kutchukhidze N, Shen S, Ding Y, Yee H, Lafaille JJ., Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 2008; 29: 114-126.
30. Herberth G, Daegelmann C, Röder S, ehrendt H, Krämer U, Borte M, et al., IL-17E but not IL-17A is associated with allergic sensitization: results from the LISA study. Pediatr Allergy Immunol 2010; 21: 1086-1090.
31. Gor DO, Rose NR, Greenspan NS,. TH1-TH2: a procrustean paradigm. Nat Immun 2003; 4: 503-505.
32. Tsuji NM, Kosaka A,. Oral tolerance: intestinal homeostasis and antigen-specific regulatory T cells. Trends Immunol 2008; 29: 532-540.
33. Gri G, Piconese S, Frossi B, Manfroi V, Merluzzi S, Tripodo C, et al., CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 2008; 29: 771-781.
34. Moldaver D, Larche M,. Immunotherapy with peptides. Allergy 2011; 66: 784-791.
35. Lombardi G, Sidhu S, Batchelor R, Lechler R,. Anergic T-cells as suppressor cells in vitro. Science 1994; 264: 1587-1589. (Pubitemid 24227713)